Search

everythinglearnresearchcommunity

for

Search:↓

Acne is strongly linked to high BMI, hair loss, menstrual issues, family history, and eating too many sweets and fatty foods, but not to excessive hair growth.

Polycystic Ovary Syndrome (PCOS) often leads to severe acne, and lifestyle changes and hormonal treatments can help manage it.

Oxidative stress and immune dysfunction are linked to both Hashimoto's thyroiditis and polycystic ovary syndrome, with diet and specific treatments important for managing these conditions.

Different treatments for PCOS should be tailored to the individual, including lifestyle changes and various medications.

Electrospun nanofibers might be a promising new treatment for hair loss.

The document concludes that personalized treatment, including lifestyle changes and medication, is essential for managing PCOS in teenagers, while also addressing their psychological well-being.

PCOS is a common hormonal disorder with symptoms like irregular periods and excess hair growth, managed with lifestyle changes and medications.

Acupuncture and moxibustion may help treat hair loss, but more research is needed.

Cognitions significantly influence Trichotillomania, suggesting cognitive therapies could help.

Women with irregular periods and/or excessive body hair are more likely to have polycystic ovaries, and this condition is linked to higher health risks.

AFM can help diagnose lichen planopilaris by identifying specific hair structure changes.

Diffuse hair loss in women is often linked to thyroid problems.

Overweight women with PCOS are more likely to have excess male hormones.

Higher substance P levels may cause discomfort in hair loss patients.

Oral isotretinoin may slightly improve acne but increases the risk of side effects like dry lips and skin; more research is needed to understand its full risks and benefits.

Adding celecoxib to chemotherapy improves survival and quality of life for gastric cancer patients with positive COX-2.

Anti-SSB antibodies are useful for diagnosing systemic lupus erythematosus and are linked to specific symptoms.

Women with Polycystic Ovary Syndrome (PCOS) often have higher levels of anxiety and depression, especially if they live in rural areas, have less education, don't have children, are over 30, or are obese.

Most hospitalized COVID-19 survivors in the study experienced long-term symptoms, affecting their daily life and mental functions.

Nirmatrelvir/Ritonavir treatment may lead to a weaker immune response to COVID-19, but doesn't affect the chance of rebound.

Metformin lowers gremlin-1 and improves insulin resistance in women with PCOS.

Certain gene variations and different levels of BDNF and CRH hormones are linked to vitiligo.

Higher levels of PD-L1 are linked to more severe hair loss in people with Alopecia Areata.

A COVID-19 patient had severe and long-lasting skin issues and unusual hair loss.

Creating specific biological indicators is important for early detection and treatment of PCOS.

Hair loss is common in autoimmune diseases and can be an early sign of the condition, often requiring prompt treatment to prevent permanent damage.

5-alpha reductase inhibitors slightly reduce urinary symptoms and may lower surgery and acute retention risks in men.

The new minoxidil gel reduces runoff and improves eyebrow hair growth.

The scalp microbiome is more diverse and may be more important in hair loss than the gut microbiome.

A blood test level of 3.2 ng/mL of Antimüllerian hormone is good for identifying polycystic ovarian morphology in European women aged 25–45.